Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Assets Average: 2010-2025

Historic Assets Average for BIO-TECHNE (TECH) over the last 15 years, with Sep 2025 value amounting to $2.5 billion.

  • BIO-TECHNE's Assets Average fell 6.54% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 6.54%. This contributed to the annual value of $2.6 billion for FY2025, which is 1.51% down from last year.
  • Per BIO-TECHNE's latest filing, its Assets Average stood at $2.5 billion for Q3 2025, which was down 2.27% from $2.6 billion recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Assets Average peaked at $2.7 billion during Q4 2023, and registered a low of $2.1 billion during Q1 2021.
  • For the 3-year period, BIO-TECHNE's Assets Average averaged around $2.7 billion, with its median value being $2.7 billion (2023).
  • Per our database at Business Quant, BIO-TECHNE's Assets Average climbed by 16.38% in 2023 and then fell by 6.54% in 2025.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Assets Average stood at $2.3 billion in 2021, then grew by 3.04% to $2.4 billion in 2022, then rose by 16.38% to $2.7 billion in 2023, then decreased by 1.45% to $2.7 billion in 2024, then declined by 6.54% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q3 2025, $2.6 billion for Q2 2025, and $2.7 billion during Q1 2025.